shubham corporation

GIDC, Valsad, Gujarat

Diacap Ultra is a gamma-sterilised, hollow-fibre membrane filter made of high-grade Polysulfone fibre. It is intended for use as a bacterial and pyrogen filter for manufacturing ultrapure dialysis fluid in Dialog, Dialog Advanced and Dialog+ dialysis machines. The filter is a central component of B. Braun's "UltraPureFluid" system (UPF) and can also be used for the preparation of volume replacement solution for HF/HDF Online therapy with the Dialog machine. Shelf life: 36 months Product benefits of Diacap Ultra:

• Highly adsorptive Polysulfone membrane: bacteria and endotoxin retention rating > 106IU/ml
• Above-average filter service life: 150 treatments or approx. 900 hours of operation
• High mechanical stability of Polysulfone fibres
• Simple and efficient preparation
• Long service life means high cost-effectiveness

Benefits of ultrapure dialysis fluid:

• Significantly improves dialysis treatment quality
• Markedly reduces chronic inflammatory processes
• Beneficial impact on dialysis patients' nutritional condition and quality of life
• Positive effect on residual renal function in patients recently dependent on dialysis

• Purification of incoming water for dialysis
• Preparation of ultrapure dialysis fluid
• Online preparation of sterile substitution fluid*
• Equipped with the Polyamix membrane
• High bacterial and endotoxin retention capabilities, both throughout the treatment and during subsequent sessions
• Convenient disinfection**

* In combination with an additional single use ultrafilter and with the Gambro AK 200 ULTRA and AK 200 ULTRA S machines. ** When the U 8000 S ultrafilter is used in combination with the Gambro AK 95, AK 95 S, AK 200, AK 200 S, AK 200 ULTRA and AK 200 ULTRA S machines, only the disinfectants recommended in the operators manual should be used. Furthermore, the disinfection should follow the procedure described in the operators manual.

DIASAFE plus is an integral part of contemporary dialysis machines. Only three handling steps are necessary to install or exchange DIASAFE plus (Fig. 1):

• Open the locks of the filter holder
• Slide DISASAFE plus filter into the guide grooves
• Close the locks - DIASAFE plus is ready to use
• Despite significant improvements in the quality and efficacy of haemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients. Today, almost every other dialysis patient dies from cardiovascular complications.
• Fresenius Medical Care is supporting nephrologists worldwide in reducing their patients risks for cardiovascular morbidity and mortality. Innovative membranes like Fresenius Polysulfone and Helixone, modern monitoring devices like the Blood Volume Monitor, the Blood Temperature Monitor and Online Clearance Monitoring (OCM ), ultrapure dialysis fluid prepared with DIASAFE plus and modern ONLINE haemodiafiltration systems support the reduction of CVD risk factors. Moreover, one of our major goals in the coming years is the development and implementation of innovative new therapies and products that further improve the cardiovascular prognosis of dialysis patients.

Despite significant improvements in the quality and efficacy of haemodialysis therapy in recent years, cardiovascular disease (CVD) remains the leading cause of death for dialysis patients.

Today, almost every other dialysis patient dies from cardiovascular complications. Fresenius Medical Care is supporting nephrologists worldwide in reducing their patients risks for cardiovascular morbidity and mortality. Innovative membranes like Fresenius Polysulfone and Helixone, modern monitoring devices like the Blood Volume Monitor, the Blood Temperature Monitor and Online Clearance Monitoring (OCM ), ultrapure dialysis fluid prepared with DIASAFE plus and modern ONLINE haemodiafiltration systems support the reduction of CVD risk factors. Moreover, one of our major goals in the coming years is the development and implementation of innovative new therapies and products in Nephrology that further improve the cardiovascular prognosis of dialysis patients. The quality and purity of the dialysis fluid are of major concern in modern-day renal replacement therapies, as large volumes of dialysis fluid come into contact with the patients bloodstream during each treatment. Bacterial endotoxins present in contaminated dialysis fluid may elicit undesirable acute reactions and influence the long-term outcome of patients on chronic haemodialysis. Although water used for the production of dialysis fluid is treated by a series of purification steps, it still may not meet the stringent requirements on bacterial contamination levels laid down by various regulatory bodies. By the application of special filters that are highly efficient in retaining bacterial contamination, the required purity grades of dialysis fluid can be achieved easily. The DIASAFE plus filter, located at the end of the water treatment chain, ensure the safe production of ultrapure dialysis fluid. This is attributed to the excellent endotoxin retention capabilities of its Fresenius Polysulfone fibres.

Fresenius Basic Diasafe Plus Filter 4008 B is used to purify with the dialysis fluid. Dialysis fluid may contain microbial impurities like endotoxins that are derived from bacterial fragments. These endotoxins may cause an adverse effect on the dialysis patient. We at Shubham Corporation, offer with Diasafe Plus Filter 4008 B that helps to overcome with the contaminated dialysis fluid.

M200301 Fresenius Medical Care Basic + Diasafe Plus 4008 B